SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Intermediate follow-up) — Isaac Newton

PatientIsaac Newton
Date of birth1976-01-04
IdentifiersMRN HR-EN011-SYN; SSN (made up) 000-11-6840
Document date2026-10-08
AuthorRupert Okonkwo-Fairbanks, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Ten-day review of metal and laboratory results; occupational and environmental medicine consultation today. [S]

History of Present Illness

Mr. Newton returns ten days after his first visit. He has not entered the laboratory since then; the university safety office sealed it four days ago, after measuring mercury vapor, and removed the mercury and arsenic compounds. He has moved out of the rooms next to it. He has kept the sleep diary and a fixed rising time, sleeps about four hours, and has stopped working at night, but still dozes in his chair in the evening. He eats two small meals a day. He met by chance a friend to whom he had written an odd letter and asked him to pass on his apology; he says the ideas that friends were plotting against him now seem to him to have come out of exhaustion, though he still feels slighted by one colleague. He has had no thoughts of death, of harming himself, or of harming anyone. He saw Dr. Mbeki-Lindström of occupational and environmental medicine this morning. [S]

ElementDetail
ExposureNone since intake; laboratory sealed; mercury vapor measured; chemicals removed
SleepAbout four hours; no night work; evening dozing continues
Appetite and weightTwo small meals a day; 63.8 kg, down 0.2 kg
Suspicious ideasLargely given up; he attributes them to exhaustion and has apologized
SafetyNo suicidal thoughts and no thoughts of harming others
PHQ-919, down from 20; item 9 scored 0

Review of Systems

SystemResultFinding
ConstitutionalPositivePoor appetite; tired; no fever
Ears, nose, mouth, and throatNegativeNo bleeding gums, mouth ulcers, metallic taste, or excess salivation
NeurologicalNegativeNo tremor, numbness, tingling, or weakness; handwriting unchanged
GenitourinaryNegativeNo frothy urine or swelling
PsychiatricPositiveLow mood, loss of interest, poor concentration, early waking; no elevated mood, racing thoughts, or reduced need for sleep with high energy; no hallucinations

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route2026-10-08activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-08Body height170cmS
2026-10-08Body weight63.8kgS
2026-10-08Body mass index (BMI) [Ratio]22.1kg/m2S
2026-10-08Systolic blood pressure122mm[Hg]S
2026-10-08Diastolic blood pressure76mm[Hg]S
2026-10-08Heart rate80/minS
2026-10-08Respiratory rate14/minS
2026-10-08Body temperature36.6CelS
2026-10-08Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-08Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]19{score}S

Physical Exam

Vital signs recorded on 2026-10-08; see the Vital Signs section. [S]

SystemFinding
GeneralThin, tired, neatly dressed
MouthGums pink and firm; no gingivitis, stomatitis, or excess saliva
NeurologicalNo postural or intention tremor of the hands, eyelids, or lips; finger-nose and spiral drawing normal; handwriting steady; normal strength, reflexes, and sensation, including vibration at the toes
Mental statusCourteous and engaged; mood "low"; affect constricted; thought process linear; no fixed false beliefs; a residual sense of being slighted by a colleague, held with doubt; no hallucinations; no suicidal or homicidal ideation; insight good

Problems

ProblemClinical statusVerificationCodeProvenance
A year of poor sleep and poor appetite with 4 kg weight loss, two weeks of near-total sleeplessness, low spirits, and suspicious thoughts that colleagues and friends were plotting against him, now partly doubted; under evaluation for depression, a toxic cause, and other medical causesresolvedconfirmed R45.89S — Synthetic presenting concern echoing the poor sleep, poor appetite, distress, and retracted suspicions documented in his letters of September 1693; superseded by the diagnoses at the second visit.
Occupational exposure to elemental and inorganic mercury, with lesser exposure to lead, antimony, and arsenic compounds, from heating metals in an unventilated private laboratoryactiveconfirmed Z57.5S — Synthetic modern exposure echoing his documented chemical and alchemical work with metals, including mercury; no level of historical exposure is asserted.
Major depressive disorder, single episode, severe, without psychotic features (PHQ-9 20 at intake): a year of poor sleep and appetite with weight loss, low mood, poor concentration, and suspicious ideas held with partial insight; medical causes excluded; the contribution of low-level mercury exposure is uncertainactiveconfirmed F32.2S — Synthetic modern diagnosis. His sleeplessness, poor appetite, distress, and melancholy in 1693 are documented (D); calling them major depression is a modern reading, and mercury poisoning and other explanations proposed later are disputed (R).
Chronic insomnia comorbid with depression: sleep onset and maintenance difficulty for a year, with two weeks of near-total sleeplessness before intakeactiveconfirmed G47.00S — Synthetic diagnosis echoing his documented sleeplessness.
Raised urine mercury from occupational exposure (24-hour urine 46 ug/L, 41 ug/g creatinine; blood 9.4 ug/L) without tremor, gingivitis, erethism, neuropathy, or kidney injury; below the levels linked to overt toxicityactiveconfirmed R82.6S — Synthetic result echoing his documented work with mercury; it does not assert that he was poisoned (see CLM-0011, R, disputed).

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPHQ-9Baseline, then at least monthly during acute treatment; every 2 to 4 weeks in continuationCompleted today19, down from 20; item 9 scored 0
SurveySuicide and violence risk reassessment (C-SSRS Since Last Visit, PHQ-9 item 9, and thoughts of harming others)Every visit during active treatmentCompleted todayNo suicidal thoughts, intent, plan, or behavior; no thoughts of harming others. Protective factors unchanged; the laboratory's toxic chemicals have been removed
LaboratoryWorkup for medical causes (blood count, metabolic panel, TSH, vitamin B12)Once, at the initial depression workupCompleted todayResults from the first visit reviewed today: all normal
SurveyBipolar screen at the initial workupOnce, at the initial depression workupCompleted todayNo past manic or hypomanic episode on interview today; no Mood Disorder Questionnaire score is recorded
Laboratory24-hour urine mercury with creatinine correction, and blood mercuryAt the exposure assessment, then 4 to 6 weeks after removal and at 3 monthsCompleted todayResults from the first visit reviewed today: urine 46 ug/L and 41 ug/g creatinine, blood 9.4 ug/L, all raised; blood lead 2.4 ug/dL, normal; repeat in about three weeks
LaboratoryKidney function and urine protein (creatinine, eGFR, urine albumin-to-creatinine ratio)At the exposure assessment and at 3 monthsCompleted todayResults from the first visit reviewed today: creatinine 0.92 mg/dL, eGFR 101, ratio 9 mg/g; dipstick protein negative
ExaminationSigns of mercury toxicity: tremor (postural and intention), handwriting, gums and mouth, erethism, peripheral neuropathyAt the exposure assessment and at each follow-up while levels are raisedCompleted todayNo tremor, gingivitis, stomatitis, or neuropathy; no erethism beyond what his depression explains
Self-managementRemoval from exposure and workplace hazard assessmentAt once, then until the workplace is safeCompleted todayLaboratory sealed; mercury vapor 0.08 mg/m3 at the furnace (NIOSH limit 0.05 mg/m3 averaged over a shift; OSHA 0.1 mg/m3); chemicals removed; decontamination and a fume hood ordered
Medication safetyChelation and provoked (chelator-challenge) urine testingOnly for symptomatic patients with high levels, decided with a medical toxicologistNot indicatedUrine mercury below 100 ug/L with no tremor, gingivitis, or kidney injury; removal from exposure comes first, and provoked testing is not valid
Medication safetySSRI tolerability check two weeks after starting2 weeks after starting and after each dose changeDueSertraline starts today
ReferralOccupational and environmental medicine (medical toxicology) consultationFor raised urine mercury with neuropsychiatric symptomsCompleted todaySeen today; chelation not indicated; return-to-work conditions set
ExaminationWeight and nutritionEvery visit while weight is below his usualCompleted today63.8 kg, down 0.2 kg; two small meals a day
Self-managementPsychotherapy, sleep, and activityEvery visit during active treatmentCompleted todayCBT booked; CBT-I sleep window set; walks most days
LaboratoryLithium, anticonvulsant, or antipsychotic monitoring (levels, metabolic tests, AIMS)Only on those drugsNot indicatedTreated with an SSRI only; no antipsychotic, because there are no psychotic features

Goal progress:

Guideline basis: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) (2022); Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016); Evaluating Mercury Exposure: Information for Health Care Providers (2018); NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026); American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010); Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013)

Follow-up: Depression and exposure review in three weeks with a repeat 24-hour urine mercury; telephone contact sooner if needed. Next scheduled visit 2026-10-22: preventive health visit at 50. [S]